27 November 2023
27 November 2023
The Clinical Trials Arena team also review assets in oncology, gastrointestinal diseases and ophthalmology.
Companies plan to submit the supplemental data on Dupixent to the US Food and Drug Administration (FDA) by the end of 2023.
Interim efficacy assessment data showed that the trial met the primary endpoint of progression-free survival.
The findings match the accuracy of radiologists in detecting breast cancer when the AI threshold is appropriately set.
A study published by the University of Ottawa found that the majority of Canada-based trials do not meet all reporting requirements.
Using the data from this study, the company is moving forward with a Phase I/II clinical trial in the Gambia, Africa.
The trial is supported by a £2m grant from the UK National Institute for Health and Care Research.
The SCI-210 therapy combines cannabidiol and SciSparc's Palmitoylethanolamide, designed to reduce autism spectrum disorder (ASD) symptoms.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
